BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
3 hedge funds and large institutions have $29.3K invested in Biodexa Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $28.5K | -$12.8K | -317 | -31% |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $628 | -$377 | -9 | -38% |
|
|
CIM
3
Contravisory Investment Management
Norwell,
Massachusetts
| $162 | – | – | – |
|
|
SS
4
SBI Securities
Tokyo,
Japan
| $4 | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$9.19K | -130 | Closed |
|
6
Morgan Stanley
New York
| – | -$4.04K | -57 | Closed |
|
|
GI
7
GAMMA Investing
Foster City,
California
| – | -$81 | -1 | Closed |
|